Literature DB >> 8174286

P300 event-related potentials in epileptic children.

Y Sunaga1, A Hikima, T Otsuka, K Nagashima, T Kuroume.   

Abstract

To evaluate the cognitive function of epileptic children, we examined P300 in 50 patients, 32 with idiopathic generalized epilepsy (IGE) and 18 with temporal lobe epilepsy (TLE), and 39 normal children. There were significant negative correlations between age and P300 latencies at Pz and Cz in normal controls. For data analysis, we used the age-corrected latency, which was calculated as the interval between the actual and predicted P300 latencies. The predicted latency was calculated with the regression equation as the relationship between P300 latency and age in normal controls. The age-corrected P300 latencies recorded from Pz and Cz were significantly longer in patients with IGE (41.5 +/- 13.1, 42.0 +/- 12.5) than in control subjects (0 +/- 7.5, 0 +/- 7.9). There were no significant differences in age-corrected P300 latencies between patients with TLE (21.2 +/- 17.6, 31.5 +/- 17.0) and controls, or IGE and TLE. Recently, it was considered that the mesencephalic reticular formation and thalamus may play major roles in the genesis of generalized epilepsy, so we speculate that dysfunction of these systems may contribute to the prolongation of P300 in children with idiopathic generalized epilepsy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174286     DOI: 10.1177/155005949402500106

Source DB:  PubMed          Journal:  Clin Electroencephalogr        ISSN: 0009-9155


  2 in total

1.  Auditory and Visual P300 Responses in Early Cognitive Assessment of Children and Adolescents with Epilepsy.

Authors:  Sangeeta Gupta; Arun Prasad; Ramji Singh; Gaurav Gupta
Journal:  J Pediatr Neurosci       Date:  2020-03-18

Review 2.  Application of the P300 Event-Related Potential in the Diagnosis of Epilepsy Disorder: A Review.

Authors:  Kandhasamy Sowndhararajan; Minju Kim; Ponnuvel Deepa; Se Jin Park; Songmun Kim
Journal:  Sci Pharm       Date:  2018-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.